IGF2BP2 and colorectal cancer: Down-regulated FTO and ALKBH5 co-operatively activate FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer [132] (Table 3).